<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>chlorproMAZINE</title><link>http://www.unboundmedicine.com/medline/ebm/research/chlorproMAZINE</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Pharmacological characterization of a Bombyx mori alpha-adrenergic-like octopamine receptor stably expressed in a mammalian cell line.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19918790/full_citation/Pharmacological_characterization_of_a_Bombyx_mori_alpha_adrenergic_like_octopamine_receptor_stably_expressed_in_a_mammalian_cell_line_</link><description>Huang J, Hamasaki T, Ozoe Y <br/><span class="title">Pharmacological characterization of a Bombyx mori alpha-adrenergic-like octopamine receptor stably expressed in a mammalian cell line. [JOURNAL ARTICLE]</span><br/><span class="source" title="Archives of insect biochemistry and physiology">Arch Insect Biochem Physiol 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19918790/abstract/Pharmacological_characterization_of_a_Bombyx_mori_alpha_adrenergic_like_octopamine_receptor_stably_expressed_in_a_mammalian_cell_line_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19918790/full_citation/Pharmacological_characterization_of_a_Bombyx_mori_alpha_adrenergic_like_octopamine_receptor_stably_expressed_in_a_mammalian_cell_line_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19918790/Pharmacological_characterization_of_a_Bombyx_mori_alpha_adrenergic_like_octopamine_receptor_stably_expressed_in_a_mammalian_cell_line_">Find Related Articles</a> </description></item><item><title>Evidence for dopamine involvement in ambulation promoted by pulegone in mice.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19917306/full_citation/Evidence_for_dopamine_involvement_in_ambulation_promoted_by_pulegone_in_mice_</link><description>Umezu T <br/><span class="title">Evidence for dopamine involvement in ambulation promoted by pulegone in mice. [JOURNAL ARTICLE]</span><br/><span class="source" title="Pharmacology, biochemistry, and behavior">Pharmacol Biochem Behav 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19917306/abstract/Evidence_for_dopamine_involvement_in_ambulation_promoted_by_pulegone_in_mice_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19917306/full_citation/Evidence_for_dopamine_involvement_in_ambulation_promoted_by_pulegone_in_mice_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19917306/Evidence_for_dopamine_involvement_in_ambulation_promoted_by_pulegone_in_mice_">Find Related Articles</a> </description></item><item><title>Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19909228/full_citation/Unraveling_Monoamine_Receptors_Involved_in_the_Action_of_Typical_and_Atypical_Antipsychotics_on_Glutamatergic_and_Serotonergic_Transmission_in_Prefrontal_Cortex_</link><description>López-Gil X, Artigas F, Adell A <br/><span class="title">Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current pharmaceutical design">Curr Pharm Des 2009 Nov 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19909228/abstract/Unraveling_Monoamine_Receptors_Involved_in_the_Action_of_Typical_and_Atypical_Antipsychotics_on_Glutamatergic_and_Serotonergic_Transmission_in_Prefrontal_Cortex_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19909228/full_citation/Unraveling_Monoamine_Receptors_Involved_in_the_Action_of_Typical_and_Atypical_Antipsychotics_on_Glutamatergic_and_Serotonergic_Transmission_in_Prefrontal_Cortex_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19909228/Unraveling_Monoamine_Receptors_Involved_in_the_Action_of_Typical_and_Atypical_Antipsychotics_on_Glutamatergic_and_Serotonergic_Transmission_in_Prefrontal_Cortex_">Find Related Articles</a> </description></item><item><title>Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19909227/full_citation/Third_Generation_Antipsychotic_Drugs:_Partial_Agonism_or_Receptor_Functional_Selectivity</link><description>Mailman RB, Murthy V <br/><span class="title">Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity? [JOURNAL ARTICLE]</span><br/><span class="source" title="Current pharmaceutical design">Curr Pharm Des 2009 Nov 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19909227/abstract/Third_Generation_Antipsychotic_Drugs:_Partial_Agonism_or_Receptor_Functional_Selectivity">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19909227/full_citation/Third_Generation_Antipsychotic_Drugs:_Partial_Agonism_or_Receptor_Functional_Selectivity">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19909227/Third_Generation_Antipsychotic_Drugs:_Partial_Agonism_or_Receptor_Functional_Selectivity">Find Related Articles</a> </description></item><item><title>Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19902987/full_citation/Polymorphism_of_Human_Cytochrome_P450_2D6_and_Its_Clinical_Significance:_Part_II_</link><description>Zhou SF <br/><span class="title">Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical pharmacokinetics">Clin Pharmacokinet 2009 Dec 1; 48(12):761-804.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19902987/abstract/Polymorphism_of_Human_Cytochrome_P450_2D6_and_Its_Clinical_Significance:_Part_II_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19902987/full_citation/Polymorphism_of_Human_Cytochrome_P450_2D6_and_Its_Clinical_Significance:_Part_II_">Full Citation</a></description></item><item><title>Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19897178/full_citation/Antipsychotic_Dose_Equivalents_and_Dose_Years:_A_Standardized_Method_for_Comparing_Exposure_to_Different_Drugs_</link><description>Andreasen NC, Pressler M, Nopoulos P, et al. <br/><span class="title">Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs. [JOURNAL ARTICLE]</span><br/><span class="source" title="Biological psychiatry">Biol Psychiatry 2009 Nov 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19897178/abstract/Antipsychotic_Dose_Equivalents_and_Dose_Years:_A_Standardized_Method_for_Comparing_Exposure_to_Different_Drugs_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19897178/full_citation/Antipsychotic_Dose_Equivalents_and_Dose_Years:_A_Standardized_Method_for_Comparing_Exposure_to_Different_Drugs_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0006-3223(09)01125-1">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19897178/Antipsychotic_Dose_Equivalents_and_Dose_Years:_A_Standardized_Method_for_Comparing_Exposure_to_Different_Drugs_">Find Related Articles</a> </description></item><item><title>A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19895780/full_citation/A_double_blind_randomized_study_of_minocycline_for_the_treatment_of_negative_and_cognitive_symptoms_in_early_phase_schizophrenia_</link><description>Levkovitz Y, Mendlovich S, Riwkes S, et al. <br/><span class="title">A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of clinical psychiatry">J Clin Psychiatry 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19895780/abstract/A_double_blind_randomized_study_of_minocycline_for_the_treatment_of_negative_and_cognitive_symptoms_in_early_phase_schizophrenia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19895780/full_citation/A_double_blind_randomized_study_of_minocycline_for_the_treatment_of_negative_and_cognitive_symptoms_in_early_phase_schizophrenia_">Full Citation</a> | <a href="http://article.psychiatrist.com/%3fContentType=START%26amp;ID=10006544">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19895780/A_double_blind_randomized_study_of_minocycline_for_the_treatment_of_negative_and_cognitive_symptoms_in_early_phase_schizophrenia_">Find Related Articles</a> </description></item><item><title>Chapter 40 History of neurology in France.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19892143/full_citation/Chapter_40_History_of_neurology_in_France_</link><description>Clarac F, Boller F <br/><span class="title">Chapter 40 History of neurology in France. [Journal Article]</span><br/><span class="source" title="Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn">Handb Clin Neurol 2009.:629-56.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19892143/abstract/Chapter_40_History_of_neurology_in_France_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19892143/full_citation/Chapter_40_History_of_neurology_in_France_">Full Citation</a></description></item><item><title>Effects of endocytosis inhibitors on internalization of human IgG by Caco-2 human intestinal epithelial cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19879882/full_citation/Effects_of_endocytosis_inhibitors_on_internalization_of_human_IgG_by_Caco_2_human_intestinal_epithelial_cells_</link><description>Sato K, Nagai J, Mitsui N, et al. <br/><span class="title">Effects of endocytosis inhibitors on internalization of human IgG by Caco-2 human intestinal epithelial cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="Life sciences">Life Sci 2009 Oct 29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19879882/abstract/Effects_of_endocytosis_inhibitors_on_internalization_of_human_IgG_by_Caco_2_human_intestinal_epithelial_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19879882/full_citation/Effects_of_endocytosis_inhibitors_on_internalization_of_human_IgG_by_Caco_2_human_intestinal_epithelial_cells_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19879882/Effects_of_endocytosis_inhibitors_on_internalization_of_human_IgG_by_Caco_2_human_intestinal_epithelial_cells_">Find Related Articles</a> </description></item><item><title>Contractile actions of L-type Ca(2+)-agonists in human vas deferens and effects of structurally different Ca(2+)-antagonists.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19878664/full_citation/Contractile_actions_of_L_type_Ca_2+__agonists_in_human_vas_deferens_and_effects_of_structurally_different_Ca_2+__antagonists_</link><description>Amobi N, Guillebaud J, Smith IC <br/><span class="title">Contractile actions of L-type Ca(2+)-agonists in human vas deferens and effects of structurally different Ca(2+)-antagonists. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of pharmacology">Eur J Pharmacol 2009 Oct 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19878664/abstract/Contractile_actions_of_L_type_Ca_2+__agonists_in_human_vas_deferens_and_effects_of_structurally_different_Ca_2+__antagonists_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19878664/full_citation/Contractile_actions_of_L_type_Ca_2+__agonists_in_human_vas_deferens_and_effects_of_structurally_different_Ca_2+__antagonists_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19878664/Contractile_actions_of_L_type_Ca_2+__agonists_in_human_vas_deferens_and_effects_of_structurally_different_Ca_2+__antagonists_">Find Related Articles</a> </description></item></channel></rss>